Paloma Partners Management CO Myovant Sciences Ltd. Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$17.07 - $24.56 $309,496 - $445,297
-18,131 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$20.46 - $25.18 $370,960 - $456,538
18,131 New
18,131 $373,000
Q1 2020

May 15, 2020
SELL
$6.55 - $14.76 $69,325 - $156,219
-10,584 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$4.2 - $19.21 $44,452 - $203,318
10,584 New
10,584 $164,000

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email